Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $269.64 | 5 | 84.7% |
| Education | $48.65 | 3 | 15.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $125.00 | 1 | $0 (2019) |
| Roche Diagnostics Corporation | $105.92 | 1 | $0 (2019) |
| AMAG Pharmaceuticals, Inc. | $48.65 | 3 | $0 (2018) |
| Exeltis, USA Inc. | $14.80 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $13.22 | 1 | $0 (2017) |
| Avion Pharmaceuticals | $10.70 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $245.72 | 3 | AbbVie, Inc. ($125.00) |
| 2018 | $35.62 | 3 | AMAG Pharmaceuticals, Inc. ($24.92) |
| 2017 | $36.95 | 2 | AMAG Pharmaceuticals, Inc. ($23.73) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2019 | Roche Diagnostics Corporation | RS Harmony Test Related Products (Device) | Food and Beverage | In-kind items and services | $105.92 | General |
| Category: Sequencing | ||||||
| 09/17/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Endocrinology | ||||||
| 05/03/2019 | Exeltis, USA Inc. | Vitafol Ultra (Drug) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: Prenatal Vitamin | ||||||
| 09/14/2018 | Avion Pharmaceuticals | Balcoltra (Drug) | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: Oral Contraceptive | ||||||
| 04/13/2018 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $12.61 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 02/14/2018 | AMAG Pharmaceuticals, Inc. | INTRAROSA (Drug) | Education | In-kind items and services | $12.31 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 10/06/2017 | AMAG Pharmaceuticals, Inc. | — | Education | In-kind items and services | $23.73 | General |
| 03/03/2017 | Merck Sharp & Dohme Corporation | NUVARING (Drug), NEXPLANON | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 178 | 253 | $34,550 | $19,572 |
| 2022 | 7 | 370 | 505 | $87,850 | $43,037 |
| 2021 | 1 | 26 | 26 | $5,200 | $2,920 |
| 2020 | 2 | 40 | 49 | $11,500 | $4,821 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2023 | 46 | 62 | $9,300 | $8,666 | 93.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 41 | 63 | $10,800 | $3,571 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 32 | $6,350 | $3,074 | 48.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 22 | 32 | $3,200 | $1,707 | 53.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 25 | 34 | $3,400 | $1,379 | 40.6% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 20 | 30 | $1,500 | $1,176 | 78.4% |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2022 | 62 | 69 | $10,250 | $9,554 | 93.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 89 | $17,750 | $8,951 | 50.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 56 | 56 | $19,500 | $7,141 | 36.6% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 91 | 158 | $11,600 | $6,432 | 55.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 62 | 62 | $15,450 | $5,162 | 33.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 41 | 55 | $10,900 | $3,561 | 32.7% |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | Office | 2022 | 15 | 16 | $2,400 | $2,236 | 93.2% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 26 | 26 | $5,200 | $2,920 | 56.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 26 | 34 | $8,500 | $3,132 | 36.8% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 14 | 15 | $3,000 | $1,689 | 56.3% |
About Dr. Sam Shahem, MD
Dr. Sam Shahem, MD is a Obstetrics & Gynecology healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790716579.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sam Shahem, MD has received a total of $318.29 in payments from pharmaceutical and medical device companies, with $245.72 received in 2019. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($269.64).
As a Medicare-enrolled provider, Shahem has provided services to 614 Medicare beneficiaries, totaling 833 services with total Medicare billing of $70,350. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Brooklyn, NY
- Active Since 07/06/2006
- Last Updated 07/08/2007
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1790716579
Products in Payments
- Orilissa (Drug) $125.00
- RS Harmony Test Related Products (Device) $105.92
- INTRAROSA (Drug) $24.92
- Vitafol Ultra (Drug) $14.80
- NUVARING (Drug) $13.22
- Balcoltra (Drug) $10.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Brooklyn
Miriam Cremer, Md, MD
Obstetrics & Gynecology — Payments: $284,535
Mark Defazio, Md, MD
Obstetrics & Gynecology — Payments: $118,334
Dr. Kathleen Morrell Smalls, Md, Mph, MD, MPH
Obstetrics & Gynecology — Payments: $57,977
Fadi Bashour, Md, MD
Obstetrics & Gynecology — Payments: $28,113
Dr. Yi-Chun Lee
Obstetrics & Gynecology — Payments: $22,016
Bahar Bybordi, Md, MD
Obstetrics & Gynecology — Payments: $9,655